All In Biotech

Drug Trial Radar · NCT03684980

LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma

Last checked: Nov 20, 2026Latest source record: Apr 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

58

Actual

Start

Nov 14, 2018

Primary completion

Nov 2027

Study completion Nov 2027

Sponsor

Lead sponsor
Memorial Sloan Kettering Cancer CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Alabama at Birmingham
First posted
Sep 26, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Early phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to test the effects of a drug called Voraxaze when it's routinely given in combination with methotrexate and rituximab, the standard treatment for CNSL.

Conditions

  • Central Nervous System Lymphoma

Interventions

  • MethotrexateDrug

    (Cohort A) will receive MTX 3 g/m2 or (Cohort B) will receive MTX 8 g/m\^2 (Cohort E) will receive MTX ≤ 3.5 g/ m2

  • RituximabDrug

    Patients will be treated with rituximab 500 mg/m\^2.

  • leucovorinDrug

    Patients will also receive standard of care leucovorin rescue starting at least 24 hours after MTX and 2 hours after Voraxaze. Cycles will be 14 days long.

  • GlucarpidaseDrug

    Glucarpidase 2000 units. Arm E 1000 units.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. number of patients that have significant reduction of serum methotrexate levelsTime frame: 1 year

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Dana Farber Cancer Institute (Data Collection and Specimen Analysis)

    Boston, Massachusetts

  • Memorial Sloan Kettering Basking Ridge

    Basking Ridge, New Jersey

  • Memorial Sloan Kettering Monmouth

    Middletown, New Jersey

  • Memorial Sloan Kettering Bergen

    Montvale, New Jersey

  • Memorial Sloan Kettering Commack

    Commack, New York

  • Memorial Sloan Kettering Westchester

    Harrison, New York

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Memorial Sloan Kettering Nassau

    Uniondale, New York

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio

  • Cleveland Clinic (Data Collection and Specimen Collection)

    Cleveland, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.